Pars Journal of Medical Sciences

The 30-year trend of the burden of kidney diseases in Iran from 1990 to 2019

Document Type : Original Article

Authors

1 Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran

2 Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran

Abstract

Introduction: The prevalence of kidney disease (KD) as a global health burden is increasing rapidly and is known as a health problem that imposes a large economic cost on health systems. The present study was conducted with the aim of investigating the 30-year trend of the burden of KD in Iran from 1990 to 2019.
Materials and Methods: This is a secondary data analysis study that provided information on the trend of KD in Iran during the years 1990 to 2019. The data related to the indicators of the burden of KD in Iran, the Eastern Mediterranean region and the global average were extracted from the Global Burden of Diseases (GBD) report. The results of the study have been reported descriptively and in the form the trend of disease burden in a 30-year period using three indices, including DALY, YLL and YLD.
Results: The highest burden of disease caused by chronic kidney diseases in the last 30 years in Iran was related to people over 50 years old, and the corresponding DALY index was lower than the average of the region and the world. In Iran, the 30-year changes of this index in a standardized form according to age was equal to -21.54 percent (from 620.34 in 1990 to 486.68 in 2019). Moreover, the highest burden of disease caused by acute glomerulonephritis in the last 30 years was related to the age group over 70 years old, and in general, the DALY index for this disease in Iran has exceeded the average of the region and the world. In Iran, the 30-year change rate of this index standardized by age was 54.94 percent (from 5.84 in 1990 to 9.05 in 2019).
Conclusions: The results of the study showed that the burden of KD is increasing over time, especially in older age and due to acute glomerulonephritis. Therefore, it is necessary to develop and implement effective preventive and treatment measures with the aim of reducing the incidence of KD and also to slow down the progress of the disease.

Keywords

  1. References:

     

    1. He JC, Chuang PY, Ma'Ayan A, Iyengar R. Systems biology of kidney diseases. Kidney international. 2012;81(1):22-39.
    2. Lv J-C, Zhang L-X. Prevalence and disease burden of chronic kidney disease. Renal Fibrosis: Mechanisms and Therapies. 2019:3-15.
    3. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PloS one. 2016;11(7):e0158765.
    4. Kim S, Lim CS, Han DC, Kim GS, Chin HJ, Kim S-J, et al. The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. Journal of Korean medical science. 2009;24(Suppl 1):S11-S21.
    5. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022 Apr;12(1):7-11.
    6. Centers for Disease Control and Prevention Chronic kidney disease (CKD) surveillance system: 2021. Available from: https://nccd.cdc.gov/ckd/default.aspx Accessed September 30, 2021.
    7. Bouya S, Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta‐Analysis and Systematic Review. Therapeutic apheresis and dialysis. 2018;22(6):594-9.
    8. Murray CJ, Evans DB, Evans D. Health systems performance assessment: debates, methods and empiricism: World Health Organization; 2003.
    9. Nejadghaderi SA, Saeedi Moghaddam S, Keykhaei M, Shobeiri P, Rezaei N, Rezaei N, Naghavi M, Larijani B, Farzadfar F. Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019. Front Endocrinol (Lausanne). 2023;14:1115833.
    10. Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low-and middle-income countries. Nephrology Dialysis Transplantation. 2016;31(6):868-74.Jones DS, Podolsky SH, Greene JA. The burden of disease and thechanging task of medicine. New England Journal of Medicine. 2012;366(25):2333-8.Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2020. Available from: http://ghdx.healthdata.org/gbd-results-tool. 13.World Health Organization. Global Health Observatory metadata WHO region Codelist. Available from:https://apps.who.int/gho/data/node.metadata.REGION?lang=enHill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease-a systematic review andmetaanalysis. PLoS One. 2016;11:0158765Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. GBD 2015 Mortality and Causes of DeathCollaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death1980-2015ystematicanalysisfotheGlobalBurdenofDiseaseStudy2015.Lancet.2016;8;388(10053):1459–544.Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.Lancet. 2015. 27;385(9987):2616–43.Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet 2020; 395 (10225): 662-4.Ke C, Liang J, Liu M. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990–2019: results from the global burden of disease study 2019. BMC Nephrol 2022; 23 (1): 17.Agudelo-Botero M, Valdez-Ortiz R, Giraldo-Rodríguez L, González-Robledo MC, Mino-León D, Rosales-Herrera MF, Cahuana-Hurtado L, Rojas-Russell ME, Dávila-Cervantes CA. Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017. BMJ Open. 2020 25;10(3):e035285.Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382:260–72.Bai, J, Yang, J-Y, Di, J-K, Shi, Y-R, Zhang, J-R, Zhou, Y. Gender and socioeconomic disparities in global burden of chronic kidney disease due to glomerulonephritis: A global analysis. Nephrology. 2023; 28 (3): 159- 67.Bosomprah S, Bjonstad EC, Musuku J, Siyumbwa N, Ngandu M, Chisunka M, Banda P, Goma F, Mweemba A. Burden of chronic kidney diseases and underlying causes in Zambia: evidence from the global burden of disease study 2019. BMC Nephrol. 2023 18;24(1):39.Guo Q, Wu S, Xu C, Wang J, Chen J. Global Disease Burden From Acute Glomerulonephritis 1990-2019. Kidney Int Rep. 2021;6(8):2212-7.Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018 1;96(6):414-422D.